VVY Stock Forecast - Vivoryon Therapeutics NV

	Vivoryon Therapeutics NV AEX:VVY	DE
N	NXP Semiconductors NV SWB:VNX	NL
E	Electricite de France SA XBER:E2F	FR
	Balchem Corp NASDAQ:BCPC	US
	NexPoint Residential Trust Inc NYSE:NXRT	US
M	Medios AG F:ILM1	DE
Z	Zoetis Inc F:ZOE	US
	Burberry Group PLC LSE:BRBY	UK
E	EQT Corp XMUN:EQ6	US
K	Kone Oyj DUS:KC4	FI
	Unicharm Corp TSE:8113	JP
D	Dupont De Nemours Inc BMV:DD	US
	Persistent Systems Ltd NSE:PERSISTENT	IN
	International Stem Cell Corp OTC:ISCO	US
	Eni SpA MIL:ENI	IT
J	J B Hunt Transport Services Inc F:JB1	US
B	Banc of California Inc F:FPB	US

Wall St Price Targets

Wall Street analysts forecast VVY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVY is 5.73 EUR with a low forecast of 5.05 EUR and a high forecast of 7.19 EUR.

324% Upside

381% Upside

504% Upside

L

LHC Group Inc

49% Upside

ProQR Therapeutics NV

419% Upside

Zentalis Pharmaceuticals Inc

46% Upside

L

LHC Group Inc

49% Upside

ProQR Therapeutics NV

419% Upside

Zentalis Pharmaceuticals Inc

46% Upside

Revenue
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

4%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

4%

Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

4%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

4%

Average Beat

What are analyst estimates?

Continue VVY Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

XETRA • EUR

05Y

F • EUR

05Y

LSE • EUR

0R3M

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

According to Wall Street analysts, the average 1-year price target for VVY is 5.73 EUR with a low forecast of 5.05 EUR and a high forecast of 7.19 EUR.

Back to Top

Vivoryon Therapeutics NV
AEX:VVY

Wall St Price Targets

VVY Price Targets Summary
Vivoryon Therapeutics NV

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue VVY Research

What is VVY's stock price target?

Price Target
5.73 EUR

Company

Help

Tools

Stocks

Vivoryon Therapeutics NV AEX:VVY

Wall St Price Targets

VVY Price Targets Summary Vivoryon Therapeutics NV

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue VVY Research

What is VVY's stock price target? Price Target 5.73 EUR

Company

Help

Tools

Stocks

Vivoryon Therapeutics NV
AEX:VVY

VVY Price Targets Summary
Vivoryon Therapeutics NV

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is VVY's stock price target?

Price Target
5.73 EUR